Theranostics
2017; 7(3):559-560.
doi:10.7150/thno.18728 This issueCite
Erratum
Active Tumor Permeation and Uptake of Surface Charge-Switchable Theranostic Nanoparticles for Imaging-Guided Photothermal/Chemo Combinatorial Therapy: Erratum
1. Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 30013, Taiwan 2. Department of Chemical Engineering, National Chung Hsing University, Taichung 402, Taiwan
✉ Corresponding authors: poemt5637com (W.-H. Chiang) and hscchiunthu.edu.tw. (H.-C. Chiu)
Citation:
Hung CC, Huang WC, Lin YW, Yu TW, Chen HH, Lin SC, Chiang WH, Chiu HC. Active Tumor Permeation and Uptake of Surface Charge-Switchable Theranostic Nanoparticles for Imaging-Guided Photothermal/Chemo Combinatorial Therapy: Erratum. Theranostics 2017; 7(3):559-560. doi:10.7150/thno.18728. https://www.thno.org/v07p0559.htm
In our paper [1] and the supplementary materials, Figure 10b and Figure S10 should be corrected as follows.
Figure 10
(a) Tumor growth inhibition profiles of the mice bearing TRAMP-C1 tumor injected with various formulations, followed by NIR laser irradiation (5 min, 1.0 W/cm2) 6 h post-injection or without any laser treatment (n = 4 per group). Morphology and size of the tumors of each group isolated from the sacrificed mice at day 15 (the end point) after the treatment. (b) Images of H&E-stained tumor sections harvested from the tumor-bearing mice receiving treatments. Scale bars are 100 μm.
H&E-stained images of major organs. The TRAMP-C1 tumor-bearing mice receiving different formulations and NIR irradiation were sacrificed 15 days post treatment. Scale bars are 100 μm.